Загрузка...
Controversies in Cancer Stem Cells: Targeting Embryonic Signaling Pathways
Selectively targeting cancer stem cells (CSCs) or tumor-initiating cells (TIC) (from this point onward referred to as CSCs) with novel agents is a rapidly emerging field of oncology. Our knowledge of CSCs and their niche microenvironments remains a nascent field. CSC’s critical dependence upon self-...
Сохранить в:
| Опубликовано в: : | Clin Cancer Res |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5207800/ https://ncbi.nlm.nih.gov/pubmed/20530695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-2934 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|